¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõÀ¯»êÈÄÇÑ¾à ¼ÛµµÀ¯»êÇѾà ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼ÛµµÀ¯»êÇѾà, #¼ÛµµÀ¯»êÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»ê, #¼ÛµµÀΰøÀ¯»ê, #À¯»êÇѾàÇÑÀÇ¿ø, #ÀΰøÀ¯»êÇÑÀÇ¿ø, #¼ÛµµÀΰøÀ¯»ê, #ÀÎõÀ¯»êÇÑ¾à ¼ÛµµÀ¯»êÇѾà,,¼ÛµµÀ¯»êÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»ê,,¼ÛµµÀΰøÀ¯»ê,,À¯»êÇѾàÇÑÀÇ¿ø,,ÀΰøÀ¯»êÇÑÀÇ¿ø,,¼ÛµµÀΰøÀ¯»ê,,ÀÎõÀ¯»êÇÑ¾à ¾È³çÇϼ¼¿ä. ¼ÛµµÀ¯»êÇѾà ÀÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼ÛµµÀ¯»êÇѾà ÀÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÀΰøÀ¯»ê, È­ÇÐÀûÀ¯»êÈÄ»ý¸®, À¯»êÈĸö°ü¸®, È­ÇÐÀûÀ¯»êÃâÇ÷, À¯»êÈÄÇѾà, È­ÇÐÀûÀ¯»êÈÄÀÓ½Å, ¼ÒÆļúÈÄ»ý¸®, À¯»êÇѾà, È­ÇÐÀûÀ¯»ê»ý¸®, À¯»ê¼ö¼úÈÄ, ¼ÒÆļö¼úÈĸöÁ¶¸®, ¼ÒÆļö¼ú, °è·ùÀ¯»êÈĸöÁ¶¸®, ÀΰøÀ¯»êÈĸöÁ¶¸®, À¯»êÈĺ¸¾à, ÀΰøÀ¯»êÈÄ, ¼ÒÆļúÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»ê, Àΰø¼öÁ¤½ÇÆÐ, È­ÇÐÀ¯»ê, È­À¯, È­ÇÐÀûÀ¯»êÇÏÇ÷, À¯»êÈÄ°ü¸®, °è·ùÀ¯»ê, °è·ùÀ¯»êÇѾàµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó °æÇÇÀû¿Ü¼±Á¶»ç¿ä¹ý, ȣħ, TENS, ¸ÆÆÄ°Ë»ç, °üÀýº¸È£´ë, °üÀýôÃߺÀ¾àħ¿ä¹ý, ·ÑÇÎ, ¸Å¼±¿ä¹ý, ¿À°ø¾àħ, ¿îµ¿Ä¡·á, ±ØÃÊ´ÜÆÄÅõ¿­Ä¡·á, Çâ±âÀÚ°¡¿ä¹ý, ÀüÀÚ¿ä¹ý, üÁö¹æÃøÁ¤, ½ÃÇÁ°Ö, ü¿­Áø´Ü(Àü½Å), ½ÉºÎ¿­Ä¡·á, ¸Æ¹Ý¼®¿Â½ÀÂòÁú±â, heat therapy, Ư¼öÃß³ª, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² ÁøÁֽà Çϴ뵿, ÀÎõ µ¿±¸ ¸¸¼®µ¿, ÀüºÏ Á¤À¾½Ã ±ÝºØµ¿, ºÎ»ê µ¿±¸ ¹üÀÏ2µ¿, ÀÎõ µ¿±¸ ¼Û¸²6µ¿, ÀÎõ ³²±¸ ÁÖ¾È5µ¿, ÀüºÏ Á¤À¾½Ã ÅÂÀθé, ÀüºÏ ¿ÏÁÖ±º »ï·ÊÀ¾, °­¿ø ȫõ±º µÎÃ̸é, Á¦ÁÖ ¼­±ÍÆ÷½Ã µµ¼øµ¿, °æ±â Àǿսà ÃÊÆòµ¿, Ãæ³² °øÁֽà ÀÌÀθé, °æºÏ °æÁֽà ±¸È²µ¿, ÀüºÏ ÀÍ»ê½Ã ¿õÆ÷¸é, Àü³² ¿µ±¤±º ¹é¼öÀ¾, ÀüºÏ ¼øⱺ ¼øâÀ¾, °æ³² â¿ø½Ã ÁøÇر¸ ³²ºóµ¿, ÀÎõ ¿¬¼ö±¸ ¼Ûµµµ¿, °æ±â ¾çÁֽà ȸ¾Ïµ¿, ÀüºÏ ±º»ê½Ã ¼Ò·æµ¿, ÀüºÏ ÀÍ»ê½Ã ¸Á¼º¸é, °æºÏ °æ»ê½Ã ¿Á°îµ¿, ¿ï»ê ºÏ±¸ ´ç»çµ¿, °æ³² °Åⱺ ÁÖ»ó¸é, Àü³² °î¼º±º Á×°î¸é, Ãæ³² û¾ç±º ´ëÄ¡¸é, °æ±â È­¼º½Ã ¾ç°¨¸é, ÀüºÏ Á¤À¾½Ã ÇϺϵ¿, Àü³² À强±º Áø¿ø¸é, ÀüºÏ ÀüÁֽà ´öÁø±¸ È£¼ºµ¿2°¡, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼ÛµµÀ¯»êÇѾàÄ¡·á ãÀ¸½Ã´Â ÀÎõ¼­±¸, ³²¾çÀ¾, Á־ȵ¿, °Ë´Ü, µµ¸²µ¿, ±¸¿ùµ¿, ¿ëÇöµ¿, µ¿±¸, ÀÎõÁÖ¾È, ³²µ¿±¸, ³íÇö°íÀܵ¿, ¼Ûµµ½Åµµ½Ã, ÀÎõ³íÇöµ¿, ´ëºÎµµ, ³²±¸, µ¿Ãᵿ, Á־ȿª, µ¿ÀÎõ, µµÈ­µ¿, °è»êµ¿, ¸¶µµ¸é, ºÎõ, Á¤¿Õµ¿, ½ÃÈï, ¼®³²µ¿, ¿¬¼öµ¿, ¼Û¸²µ¿, û¶ó, °Ë¾Ï, ¿î¼­µ¿, Áßµ¿, °¡Áµ¿, ¼Û¿ùµ¿, À²¸ñµ¿, ûÇе¿ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Jain D. Perineal scar endometriosis: a comparison of two cases. BMJ Case Rep 2013; 2013. 2. Costello MF, Shrestha B, Eden J, et al. Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 2007; 22:1200. 3. Bata MS, Al-Ramahi M, Salhab AS, et al. Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study. J Clin Pharmacol 2006; 46:925. 4. Lundström V, Landgren BM, Eneroth P, Johannisson E. The effect of a prostaglandin synthetase inhibitor on the hormonal profile and the endometrium in women. Acta Obstet Gynecol Scand Suppl 1983; 113:77. 5. Victory R, Diamond MP, Johns DA. Villar's nodule: a case report and systematic literature review of endometriosis externa of the umbilicus. J Minim Invasive Gynecol 2007; 14:23. 6. Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod 2008; 23:100. 7. Nylander M, Fr©ªssing S, Clausen HV, et al. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online 2017; 35:121.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõÀ¯»êÈÄÇÑ¾à ¼ÛµµÀ¯»êÇѾà ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÇѹæ´ÙÀ̾îÆ® ±¸¿ùµ¿ÇÑÀÇ¿ø ±Ã±ÝÇØ¿ä
´ÙÀ½±Û ÀÎõºñ¿°ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¾î¶² µµ¿òÀ»
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
612 7¿ù À̺¥Æ® Á¸½ºÅ²ÇÑÀÇ¿ø ÀÏ»êÁ¡ ¿©µå¸§6ÁÖÇÁ·ÎÁ§Æ® 0 1,120 2019-07-12
611 µµ°îÇÑÀÇ¿ø 2 1,060 2019-07-09
610 Àß³ª°¡´ÂÇÑÀÇ¿ø - ±¸¸®Ä¡Áú ÇÑÀÇ¿ø Ưº°À̺¥Æ® Àâ±â 0 1,950 2019-07-05
609 È­Á¢¸ùÇÑÀÇ¿ø 2019³â 7¿ù ¿©¸§ ¹Ùµð À̺¥Æ® 0 1,185 2019-07-02
608 Á¤À̾ÈÇÑÀÇ¿ø 7¿ù ÇÑ´Þ°£ Ãâ½Ã±â³äÀ̺¥Æ® - ÁöÄ£¿©¸§¿£ ±â·Âº¸°­À» À§.. 0 1,195 2019-07-02
607 ¹Ý¿ù´ç ¶óÀ²ÇÑÀÇ¿ø 7¿ù ÇÖÇÑ ¿©¸§À» À§ÇÑ ¸¶Áö¸· Áغñ! 0 680 2019-07-02
606 º½º½ÇÑÀÇ¿ø 7¿ù À̺¥Æ® ¨ç [Çѹ濬°í ÀÚ¿î°í] 0 1,380 2019-07-02
605 7¿ù ÂüÇÑÀÇ¿ø °æ¿Á°í, °æ¿Áȯ ÇÒÀÎ À̺¥Æ® 0 1,148 2019-06-30
604 [´ëÀüµÐ»êµ¿´Ù³ªÇÑÀÇ¿ø] 7¿ù ¸¶±×³×ƽ ü¾î À̺¥Æ® 1 2,395 2019-06-30
603 ¸íµ¿±Ô¸²ÇÑÀÇ¿ø 6¿ù ¿©¸§À̺¥Æ® 0 875 2019-06-14
602 ¿©¸§ÀÇ ½ÃÀÛ, 6¿ùµµ ½Å¼ö¸²ÇÑÀÇ¿ø ¾ÈƼ¿¡ÀÌ¡ Ä¡·á¿Í ÇÔ²²Çϼ¼¿ä(feat... 0 1,301 2019-06-14
601 6¿ù ûÁÖ ±Ô¸²ÇÑÀÇ¿ø À̺¥Æ® 0 1,284 2019-06-14
600 [È­Á¤¿ª È¿ÀçÇÑÀÇ¿ø]6¿ù À̺¥Æ® 0 2,539 2019-06-14
599 ÂüÇÑÀÇ¿ø 6¿ù ÇÒÀÎ À̺¥Æ® 0 622 2019-06-03
598 2019³â 6¿ù ¹Ùµð À̺¥Æ®- È­Á¢¸ùÇÑÀÇ¿ø 0 737 2019-05-31
597 ÁöÀ½ÇÑÀÇ¿ø ¿©¸§¸ÂÀÌ À̺¥Æ® 0 897 2019-05-31
596 [¸®»ùÇÑÀÇ¿ø ÀÏ»êÁ¡]6¿ùÀ̺¥Æ® 0 931 2019-05-31
595 [µÐ»êµ¿´Ù³ªÇÑÀÇ¿ø6¿ùÀ̺¥Æ®] µÐ»êµ¿ ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ´Ù³ª¿Í ÇÔ²² ÀÚ.. 1 1,740 2019-05-31
594 ¸¶»ê¼Û¸²ÇÑÀÇ¿ø - °¨»çÀÇ ´Þ 5¿ù ÇÒÀÎ À̺¥Æ® 0 1,502 2019-05-08
593 ºÎ»ê´ÙÀ̾îÆ® ÇÑÀÇ¿ø -5¿ù À̺¥Æ® 0 1,200 2019-05-08
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷